MedTrace Logo

Evaluation of an Automatic Segmentation Software (Pixyl.Neuro) to Track Lesions in Multiple Sclerosis Patients Via Cerebral MRI

NCT03438357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-02-08

No results posted yet for this study

Summary

Using an automatic software tool, Pixyl.Neuro, to conduct a retrospective analysis (detection of lesions + segmentation of images + tracking over time) of cerebral MRI images acquired during a prospective study of patients presenting with clinically isolated syndrome, and comparing the results against manual analysis.

Conditions

Interventions

OTHER

Analysis of cerebral MRI with automatic segmentation software

Pixyl.Neuro software versus manual analysis of lesions

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Eric Thouvenot · CHU Nimes

Eligibility

Min Age
18 Years
Max Age
56 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2022-07-06
Completion
2022-07-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03438357 on ClinicalTrials.gov